Saturday, December 2, 2023
This article is intended for primary care clinicians, gynecologists, geriatricians, and other specialists who care for women.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity, Medscape Education Clinical Briefs has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2010. Term of approval is for 1 year from this date. Each issue is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of this issue.
Note: Total credit is subject to change based on topic selection and article length.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
AAFP Accreditation Questions
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.
Medscape, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number 0461-0000-11-070-H04-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME/CE Released: 5/26/2011
Valid for credit through: 5/26/2012, 11:59 PM EST
processing....
May 26, 2011 — Gradual increases in dietary calcium intake above the first quintile in a large female cohort are not associated with further reductions in fracture risk or osteoporosis, according to the results of a prospective longitudinal cohort study reported in the May 24 issue of the BMJ.
"It is problematic to make recommendations regarding calcium intake based on the results from clinical trials and previous cohort studies," write Eva Warensjö, from Uppsala University in Uppsala, Sweden, and colleagues. "Meta-analyses of randomised trials found that supplemental calcium gave modest or no reduction in risk of fracture. Both the habitual dietary intake of calcium and vitamin D status may affect the outcome and are rarely accounted for in the design of calcium supplementation trials."
The goal of the study was to evaluate associations between long-term dietary calcium intake and the risk for any type of fractures, hip fractures, and osteoporosis. The study cohort consisted of 5022 women who participated in a subcohort of the Swedish Mammography Cohort of 61,433 women in Sweden who were born between 1914 and 1948. This population-based cohort was established in 1987, and participants were followed up for 19 years for primary outcomes of incident fractures of any type and hip fractures, which were identified from registry data.
A secondary outcome in the subcohort was osteoporosis diagnosed by dual energy x-ray absorptiometry. Repeated food frequency questionnaires allowed determination of dietary consumption.
Of 14,738 women (24%) who had a first fracture of any type during follow-up, 3871 (6%) had a first hip fracture. Osteoporosis was diagnosed in 1012 (20%) of the subcohort. For dietary calcium, the risk patterns were nonlinear. In the lowest quintile of calcium intake, the crude rate of a first fracture of any type was 17.2/1000 person-years at risk vs 14.0/1000 person-years at risk in the third quintile, yielding a multivariable adjusted hazard ratio (HR) of 1.18 (95% confidence interval [CI], 1.12 - 1.25). For a first hip fracture, the HR was 1.29 (95% CI, 1.17 - 1.43), and the odds ratio for osteoporosis was 1.47 (95% CI, 1.09 - 2.00).
The fracture rate in the first calcium quintile was more pronounced with a low vitamin D intake. Although the highest quintile of calcium intake did not further lower the risk for fractures of any type, or the risk for osteoporosis, it was associated with a higher rate of hip fracture (HR, 1.19; 95% CI, 1.06 - 1.32).
"Gradual increases in dietary calcium intake above the first quintile in our female population were not associated with further reductions in fracture risk or osteoporosis," the study authors write.
Limitations of this study include possible residual confounding; limitations inherent in dietary assessment methods; observational design, precluding conclusions regarding causality; and lack of generalizability to other people of different ethnic origins or to men.
"Dietary calcium intakes below approximately 700 mg per day in women were associated with an increased risk of hip fracture, any fracture, and of osteoporosis," the study authors conclude. "The highest reported calcium intake did not further reduce the risk of fractures of any type, or of osteoporosis, but was associated with a higher rate of hip fracture."
The Swedish Research Council supported this study. The study authors have disclosed no relevant financial relationships.
BMJ. 2011;342:d1473. Abstract
Related Link
The Mayo Clinic provides information on osteoporosis and its prevention suitable for use in patient education.
Osteoporotic fractures are frequent in older women. There is a wide range of recommendations for daily supplementation ranging from 700 mg daily in the United Kingdom to 1200 mg daily in the United States. However, meta-analyses of trials have shown no reduction in fracture risk with calcium supplementation.
This is an observational cohort study of women in Sweden to examine the association between long-term dietary calcium intake and the risk for fractures and osteoporosis in women.
